Podcasts Other S&C Critical Insights Industry and Regulatory Trends in Pharmaceutical M&A

Industry and Regulatory Trends in Pharmaceutical M&A

Published: March 24, 2021, 7:06 p.m.

In this episode of\xa0S&C\u2019s\xa0Critical Insights\xa0podcast,\xa0Frank Aquila, Global Head of M&A, and\xa0Matt Hurd, co-head of our Healthcare & Life Sciences group, examine industry and regulatory trends that will reshape pharmaceutical M&A in the coming years. Frank and Matt explore how innovation continues to drive new deal-making opportunities in the pharmaceutical industry, most recently in the development of non-traditional vaccine technologies. They also discuss the current deal landscape in pharmaceutical M&A and what we can expect from the market in the rest of 2021.